Bioxcel Therapeutics Inc (NQ: BTAI )
0.5537
+0.0037
(+0.67%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 9, 2024
Add to My Watchlist
All News about Bioxcel Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's After-Market Session
February 08, 2024
Via Benzinga
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November
December 06, 2023
Via Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Expert Ratings for BioXcel Therapeutics
November 15, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Recap: BioXcel Therapeutics Q3 Earnings
November 14, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For BioXcel Therapeutics
November 13, 2023
Via Benzinga
![](https://www.marketbeat.com/logos/articles/med_20231116075340_unlocking-ai-investment-opportunities-in-healthcar.jpg)
Unlocking AI investment opportunities in healthcare
November 16, 2023
Via MarketBeat
Exposures
Artificial Intelligence
![](https://cdn.benzinga.com/files/images/story/2023/11/14/image16.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Where BioXcel Therapeutics Stands With Analysts
September 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/14/btai.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 14, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/08/btai.png?width=1200&height=800&fit=crop)
BioXcel Therapeutics Reveals Survival Data From Prostate Cancer Combo Therapy Trial
November 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Intraday Session
October 30, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/10/25/image12.jpg?width=1200&height=800&fit=crop)
Dow Falls Over 100 Points; Alphabet Shares Tumble After Q3 Results
October 25, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/10/25/owens_corning_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 25, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/11/royal-dutch-shell-rds1600.jpg)
![](https://investorplace.com/wp-content/uploads/2014/06/investorplace-logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/25/image20.jpeg?width=1200&height=800&fit=crop)
Nasdaq Down 1.5%; Microsoft Posts Upbeat Results
October 25, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 25, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20231011512277/en/538768/22/BES_Mark.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/05/btai.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/749249/patient-checking-in-for-a-doctors-appointment.jpg)
Why Shares of BioXcel Therapeutics Fell This Week
September 28, 2023
Via The Motley Fool
Topics
Workforce
Exposures
Layoff
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023
October 05, 2023
Via Benzinga
NASDAQ: BTAI Investor Alert: Deadline on September 5, 2023 in Lawsuit Against BioXcel Therapeutics, Inc.
September 05, 2023
Via SBWire
Topics
Lawsuit
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.